TuHURA Biosciences, Inc. HURA · SEC Filings

website

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registrati...

Price1.66

Market Cap110.6 M

Float45.2 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 31, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 14, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

Form D - Notice of Exempt Offering of Securities - Item 06b

Nov 10, 2025

S-3

November 2025 SHELF

Nov 3, 2025

S-1/A

SHARE RESALE REGISTRATION

Sep 18, 2025

S-1

SHARE RESALE REGISTRATION

Aug 12, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Jun 13, 2025

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

May 8, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT